谷歌浏览器插件
订阅小程序
在清言上使用

Efficacy and Safety of Trimodulin in Patients with Severe COVID-19: Results from a Randomised, Placebo-Controlled, Double-Blind, Multicentre, Phase II Trial (Esscovid)

European journal of medical research(2024)

引用 0|浏览4
关键词
COVID-19,Immunoglobulin,Trimodulin,Early systemic inflammation,Immunomodulation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要